Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

1.

Human in vivo and in vitro hydroquinone topical bioavailability, metabolism, and disposition.

Wester RC, Melendres J, Hui X, Cox R, Serranzana S, Zhai H, Quan D, Maibach HI.

J Toxicol Environ Health A. 1998 Jun 26;54(4):301-17.

PMID:
9638901
[PubMed - indexed for MEDLINE]
3.

Assessment of topical bioavailability in vivo: the importance of stratum corneum thickness.

Kalia YN, Alberti I, Naik A, Guy RH.

Skin Pharmacol Appl Skin Physiol. 2001;14 Suppl 1:82-6. Review.

PMID:
11509911
[PubMed - indexed for MEDLINE]
4.

In vivo methods for the assessment of topical drug bioavailability.

Herkenne C, Alberti I, Naik A, Kalia YN, Mathy FX, Préat V, Guy RH.

Pharm Res. 2008 Jan;25(1):87-103. Epub 2007 Nov 6. Review.

PMID:
17985216
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Workshop report on in vivo percutaneous penetration/absorption. Washington D.C., May 1-3, 1989.

Shah VP, Flynn GL, Guy RH, Maibach HI, Schaefer H, Skelly JP, Wester RC, Yacobi A.

Skin Pharmacol. 1991;4(3):220-8. Review. No abstract available.

PMID:
1685087
[PubMed - indexed for MEDLINE]
6.

Bioavailability and newer methods of delivery of phosphorothioate radioprotectors.

Fleckenstein L, Swynnerton NF, Ludden TM, Mangold DJ.

Pharmacol Ther. 1988;39(1-3):203-12. Review. No abstract available.

PMID:
2849124
[PubMed - indexed for MEDLINE]
7.

Microbial production of hydroquinone.

Yoshikawa A, Yoshida S, Terao I.

Bioprocess Technol. 1993;16:149-61. Review. No abstract available.

PMID:
7763345
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk